Anavex Life Sciences
AVXL
#8517
Rank
โ‚ฌ0.22 B
Marketcap
2,41ย โ‚ฌ
Share price
6.98%
Change (1 day)
-73.14%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -โ‚ฌ42.2 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ45.06 Million a decrease over its 2023 earnings that were of -โ‚ฌ39.27 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ42.2 Million-6.36%
2024 -โ‚ฌ45.06 Million14.77%
2023 -โ‚ฌ39.27 Million-17.49%
2022 -โ‚ฌ47.59 Million22.96%
2021 -โ‚ฌ38.7 Million35.36%
2020 -โ‚ฌ28.59 Million12.65%
2019 -โ‚ฌ25.38 Million29.09%
2018 -โ‚ฌ19.66 Million36.33%
2017 -โ‚ฌ14.42 Million17.11%
2016 -โ‚ฌ12.32 Million20.91%
2015 -โ‚ฌ10.19 Million-6.29%
2014 -โ‚ฌ10.87 Million337.28%
2013 -โ‚ฌ2.49 Million
2008 -โ‚ฌ4.6 Million106.01%
2007 -โ‚ฌ2.24 Million8848.98%
2006 -โ‚ฌ0.03 Million-79.99%
2005 -โ‚ฌ0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
โ‚ฌ0.14 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
โ‚ฌ6.33 M-115.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚ฌ4.2 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.23 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA